RZLT compared with OVID: revenue, margins and what each company keeps, and the suppliers and customers both name

RZLTRezolute, Inc.

Mkt capRevenueRevenue

OVIDOvid Therapeutics Inc.

Mkt capRevenueRevenue

Compare

RZLTRezolute, Inc.

OVIDOvid Therapeutics Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

RZLT: latest quarter not drawable. OVID: latest quarter is a loss; flow not drawable.Method ›

Price

rebased to 0%

RZLT, solidOVID, dashed

RZLTRezolute, Inc.

3.96▼−3.88%· post 3.96

Mkt cap$382.1MRevenue—Revenue—

OVIDOvid Therapeutics Inc.

2.55▼−0.45%· post 2.54

ClosedOct 30 '26

Mkt cap$496.1MRevenue$733,000Q2 FY26Revenue$7MFY25

Compare

ClosedOct 30 '26

RZLTRezolute, Inc.

OVIDOvid Therapeutics Inc.

3.96▼−3.88%post 3.96

Price

2.55▼−0.45%post 2.54

$382.1M

Mkt cap

$496.1M

—

Revenue

$733,000Q2 FY26

—

Revenue

$7MFY25

RZLT3.96▼−3.88%vsOVID2.55▼−0.45%ClosedOct 30 '26

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only RZLT 4

XOMAXOMAsupplier

—ActiveSite Pharmaceuticalsunlistedsupplier

—Ligand Pharmaceuticalsunlistedsupplier

—Xoma (u.s.)unlistedsupplier

Shared 0

No shared counterparties.

Only OVID 7

LGNDLigand Pharmaceuticalscustomer

TAKTakedacustomer

—Northwestern Universityunlistedsupplier

—AstraZeneca

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

unlistedsupplier

3 more · OVID chain ›